Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arthroscopy Devices Market is Expected to Reach USD 5.1 Billion Globally in 2019: Transparency Market Research
CP Wire
Wednesday, November 20, 2013 - 10:44am
tags:
arthroscopy, devices
J&J shares are helped by findings on stroke-prevention medication
Marketwatch
Wednesday, November 20, 2013 - 8:41am
tags:
JNJ, Xarelto, Janssen
Illumina's MiSeqDx system receives FDA premarket clearance
Yahoo/Fly on the Wall
Wednesday, November 20, 2013 - 8:37am
tags:
MiSeqDx, FDA, Illumina, DNA sequencing
Clovis Oncology buys Ethical Oncology Science and says it will pay $200M upfront
Yahoo/AP
Wednesday, November 20, 2013 - 8:36am
tags:
Ethical Oncology Science, M&A, Clovis Oncology
EU backs Roche’s Kadycla in breast cancer
PM Live
Wednesday, November 20, 2013 - 8:33am
tags:
Europe, Roche, Kadcyla, breast cancer
Jeremy Levin: I'm an unemployed immigrant
Globes, Israel
Wednesday, November 20, 2013 - 8:32am
tags:
Teva, Pharma CEOs, Jeremy Levin
Amgen cholesterol drug appears safe, cut LDL 52 pct at 1 year-study
Yahoo/Reuters
Wednesday, November 20, 2013 - 8:31am
tags:
Amgen, cholesterol, asevolocumab, PCSK9 inhibitors
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wednesday, November 20, 2013 - 8:29am
tags:
psoriatic arthritis, Celgene, AbbVie, Amgen, JNJ, Merck, Humira, apremilast, Enbrel, Stelara, Simponi, Remicade
Inovio's DNA vaccine for MERS virus induces robust immune responses in trial
The Fly on the Wall
Wednesday, November 20, 2013 - 8:25am
tags:
MERS virus, DNA, vaccines, Inovio, SynCon
FDA panel backs approval of BioMarin's Morquio A Syndrome drug
Yahoo/Reuters
Tuesday, November 19, 2013 - 4:18pm
tags:
FDA, advisory panels, Biomarin, Morquio A Syndrome, Vimizim
Osiris says Grafix trial met primary, secondary, safety endpoints
The Fly on the Wall
Tuesday, November 19, 2013 - 4:17pm
tags:
Osiris, Grafix
WSJ: J&J’s hip-implant settlement will be lower than expected
Marketwatch
Tuesday, November 19, 2013 - 12:42pm
tags:
JNJ, hip implants, recalls
3 Things I Learned From Reading GlaxoSmithKline plc's Annual Report
Motley Fool
Tuesday, November 19, 2013 - 12:39pm
tags:
GSK
New Anticoagulant From Daiichi Sankyo Works Well In AF Patients
Forbes
Tuesday, November 19, 2013 - 12:35pm
tags:
Daiichi Sankyo, edoxaban, bloodthinners, Warfarin, atrial fibrillation
Stemline Therapeutics gains ground after saying it will report data on cancer therapy
Yahoo/AP
Tuesday, November 19, 2013 - 12:32pm
tags:
Stemline, SL-701, brain cancer
Aldoxorubicin Continues To Prove Itself As A Viable Cancer Treatment
Seeking Alpha
Tuesday, November 19, 2013 - 12:30pm
tags:
aldoxorubicin, cancer, chemotherapy, CytRx
Two Drugs, Designed To Help Patients, Actually Hurt Them
TheStreet.com
Tuesday, November 19, 2013 - 12:28pm
tags:
Vical, Anthera, varespladib, Allovectin-7
Keep an Eye on BioMarin, Amgen, Merck, and AstraZeneca Today
Motley Fool
Tuesday, November 19, 2013 - 12:24pm
tags:
Biomarin, Amgen, Merck, AstraZeneca
JLL Forms New Pharma Firm With DSM in $2.6 Billion Deal
Bloomberg
Tuesday, November 19, 2013 - 8:13am
tags:
Royal DSM, Patheon
Glaxo and Theravance Get European Marketing Approval for Relvar Ellipta
Motley Fool
Tuesday, November 19, 2013 - 8:11am
tags:
GSK, Europe, COPD, Theravance, Relvar Ellipta

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.